41 The magnitude of risk is relatively modest but highly significant; the biological mechanism is unknown although nearby are CDKN2A and CDKN2B , genes encoding cyclin-dependent kinase inhibitors involved in cancer cell biology with a postulated role in atherosclerosis through modulation of transforming growth factor beta.
← all excerpts
Genetics and the general physician: insights, applications and future challenges.
1
—
—